Charity BreakdownCanadian charity filings, itemized

Ovarian Cancer Canada/Cancer de l'Ovaire Canada

Charitable organization · North York, Ontario · BN 872974845RR0001 · Core Health Care · website

Your $100, itemizedOvarian Cancer Canada/Cancer de l'Ovaire CanadaFiscal year ended March 31, 2024
Charitable programs$39
Gifts to other charities$34
Fundraising$18
Management & admin$9
TOTAL$100
Registered

Source: T3010 return, FPE 2024-03-31. Split of total expenditures ($7,604,782) as filed with the CRA.

Ovarian Cancer Canada/Cancer de l'Ovaire Canada is a charitable organization based in North York, Ontario, classified by the CRA under core health care. In its fiscal year ending March 31, 2024, it reported $6.4M in revenue and $7.6M in expenditures. Spending exceeded revenue that year — the gap came out of reserves.

Its funding that year was roughly 37% from donations, 44% from government. In 2024, 52 other registered charities reported granting it a combined $825K.

Compared with 453 health charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 36% of peers. Its fundraising cost per donated dollar was higher than 78% of that peer group. Its highest-paid position fell in the $200,000–249,999 range. The charity reported 34 permanent full-time positions.

It reported gifts to 9 qualified donees totalling $2.6M in 2024, the largest being $1.3M to Cancer Research Society. Its filed list of directors and trustees shows 11 names.

In its own words

Research: Investing in pan-Canadian and patient-centered research across the full continuum of ovarian cancer from prevention to diagnosis to treatment to survivorship. Our research investments are enabling discoveries by establishing and growing key national scientific resources such as gold-standard ovarian cancer models patient tissue banks biorepositories and a rare tumours database. Ovarian Cancer Canada is maximizing impact through discovery pre-clinical and clinical research and transforming lives through supporting interventional and pragmatic/real-world clinical trials. Influence …

Ongoing-program description from its T3010 filing, verbatim.

The ledger, 20202024

YearRevenueSpendingProgramsFundraisingGifts outNet assets
2024$6.4M$7.6M$2.9M$1.4M$2.6M$1.2M
2023$6.2M$7.3M$2.6M$1.2M$2.9M$1.4M
2022$6.9M$6.3M$2.1M$731K$2.8M$2.5M
2021$5.4M$5.1M$4.1M$814K$1.9M$1.8M
2020$4.9M$4.5M$3M$1.2M$4,760$1.5M

Revenue printed in red where the year ran a deficit. Fiscal years by period end.

Money between charities, 2024

As reported on the donors’ own T3010 qualified-donee schedules.

What it pays

Its ten highest-paid positions, by band:

  • $200,000–249,9991 position
  • $160,000–199,9991 position
  • $120,000–159,9992 positions
  • $80,000–119,9996 positions
  • Permanent full-time positions34
  • Total compensation, all staff$3.1M

Schedule 3 of its 2024 return. The CRA discloses bands, not names or exact salaries.

Directors & trustees (2024)

Erin Barrett (director); David Power (treasurer board of directors); Karen Greve Young (chair of board of directors); Michel Brunet (director); Deborah Clark (director); Victoria Galloway (director); Lydia Bugden (director); Rowena Veylan (director); Jennifer Hollington (director); Elizabeth (Liza) Sunley (director); Abraham King (director).

As listed on its 2024 return.

Check the source

Every figure on this page is from Ovarian Cancer Canada/Cancer de l'Ovaire Canada’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 872974845RR0001), or read how we compute the receipt.